Immunopharmacologic purging of breast cancer from bone marrow for autologous bone marrow transplantation.
Shpall
E J
EJ
Department of Medicine, Duke University Medical Center, Durham, North Carolina 27710.
Anderson
I C
IC
Bast
R C
RC
Joines
W T
WT
Jones
R B
RB
Ross
M
M
Edwards
S
S
Eggleston
S
S
Johnston
C
C
Tepperberg
M
M
D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D001853:Bone Marrow / Q000187:drug effects / Q000276:immunology; D001854:Bone Marrow Cells; D016026:Bone Marrow Transplantation / Q000379:methods*; D001943:Breast Neoplasms / Q000628:therapy*; D003114:Colony-Forming Units Assay; D003131:Combined Modality Therapy; D003520:Cyclophosphamide / Q000031:analogs & derivatives / Q000627:therapeutic use; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D008280:Magnetics; D008863:Microspheres; D014182:Transplantation, Autologous; D014407:Tumor Cells, Cultured
D000911:Antibodies, Monoclonal; D003520:Cyclophosphamide; C011272:perfosfamide